We used multi-IF analyses to confirm that PD-L1+CD163+ TAMs were located mostly within the tumor stroma (Figures 2(a) and 2(b)), and in patients with necrosis, PD-L1+CD163+ TAMs were observed within necrotic tissue (Figure S4). This evidence concerns the gene CD163 and neoplasm.